The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Managing Side Effects of HIV TreatmentManaging Side Effects of HIV Treatment
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

Please interpret the reports
Mar 15, 2012

Age-50 Sex-Female Detected positive on 23 Jan 2012. Test Method-HIV VIRAL LOAD- COBAS AMPLIPREP / COBAS TAQMAN

HIV Monitor Test Report 27 Jan 15 Mar Ref Range Viral Load = 18800 591 copies/mL % CD3+/CD45+ (T-CELLS) = 83.3 81.1 61 - 88 % ABSOLUTE CD3+ LYMPHOCYTE COUNT = 1019 933 704-2346ÎL % CD3+/CD4+ (T-HELPER CELLS) = 14.1 25.1 28-54% ABSOLUTE CD4+ LYMPHOCYTE COUNT = 173 289 356-1335/ÎL % CD3+/CD8+(T-SUPPRESSOR CELLS)= 67.7 54.0 14-43 % ABSOLUTE CD8+ LYMPHOCYTE COUNT = 828 622 151-1023/ÎL CD4/CD8 RATIO = 0.21 0.46 .36-1.90

Respected Sir, She is taking the Duo Vir E kit by Cipla My questions are 1-The Cd4 count has increased from 173 to 289 in 6 that a good sign? 2-Is the decline in ABSOLUTE CD8+ LYMPHOCYTE COUNT from 828 to 622 important? 3-Cd4/CD8 ratio is .46,is it important to maintain the ratio? 4-The Vl has come down to 591 .Shal we consider the load undetectable? Can I tell her that this is significant progress.She has added several years to her life?

Please do reply sir...

Response from Dr. Henry

All those trends are reassuring-viral load down by 95%, good increase in CD4 count and CD4/CD8 ratio and would be considered a good response. KH

drug interaction
Treatment Side Affects

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint